Gleamer has acquired Pixyl and Caerus Medical, expanding its AI imaging capabilities to include MR applications.
The Paris-based company, which already offers AI solutions for X-ray, mammography, and CT, said the acquisitions will help establish it as a comprehensive provider of AI-driven radiology tools.
Pixyl specializes in brain MRI analysis and is known for its software, Pixyl.Neuro, which assists in detecting neuroinflammatory and neurodegenerative conditions, including Alzheimer’s disease. The company’s AI solution is both FDA-cleared and CE-marked, and it has been gaining traction, particularly as new reimbursement pathways emerge in the U.S.
Ad Statistics
Times Displayed: 98776
Times Visited: 6177 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
Caerus Medical focuses on musculoskeletal imaging, specifically AI analysis of lumbar spine MRIs. Its technology is designed to improve the detection of conditions such as disc herniation, stenosis, and spondylolisthesis, enhancing diagnostic precision and streamlining radiology workflows.
“With the addition of Pixyl and Caerus Medical, Gleamer now offers the most extensive proprietary AI-driven imaging portfolio in the industry,” said Christian Allouche, CEO and co-founder of Gleamer. “This move marks a transformative leap forward, empowering radiologists with cutting-edge MR applications while strengthening our leadership in medical imaging AI.”
Senan Doyle, CEO of Pixyl, said joining Gleamer would amplify the reach of its technology. “Together, we are setting new standards in AI-powered radiology and driving the future of neuroimaging.”
David Vittecoq, CEO of Caerus Medical, highlighted the benefits of the acquisition for musculoskeletal imaging. “This collaboration will fast-track the deployment of our lumbar MRI application and drive groundbreaking advancements in musculoskeletal imaging.”
Following the acquisitions, Gleamer's global workforce now exceeds 100 employees across seven countries. The integration of Pixyl and Caerus Medical into Gleamer’s AI development framework is expected to accelerate innovation in MR solutions.
